IN2014DN06781A - - Google Patents

Download PDF

Info

Publication number: IN2014DN06781A
Authority: IN; India
Prior art keywords: salt; salts; cushing; aromatase; pyrrolo
Prior art date: 2012-01-17

Application number

Other languages

English (en)

Inventor

Paul Sutton

Eric Loeser

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-01-17

Filing date

2013-01-15

Publication date

2015-05-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47604250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN06781(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-01-15 Application filed by Novartis Ag filed Critical Novartis Ag

2015-05-22 Publication of IN2014DN06781A publication Critical patent/IN2014DN06781A/en

Links

208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 3
201000010099 disease Diseases 0.000 abstract 2
108010078554 Aromatase Proteins 0.000 abstract 1
102000014654 Aromatase Human genes 0.000 abstract 1
108010009911 Cytochrome P-450 CYP11B2 Proteins 0.000 abstract 1
102100024329 Cytochrome P450 11B2, mitochondrial Human genes 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
-1 imidazol 5 yl 3 fluoro benzonitrile Chemical compound 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
150000002823 nitrates Chemical class 0.000 abstract 1
125000002467 phosphate group Chemical class [H]OP(=O)(O[H])O[*] 0.000 abstract 1
230000000069 prophylactic effect Effects 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

IN6781DEN2014 2012-01-17 2013-01-15 IN2014DN06781A (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201261587280P	2012-01-17	2012-01-17
PCT/US2013/021521 WO2013109514A1 (en)	2012-01-17	2013-01-15	New forms and salts of a dihydropyrrolo[1,2-c]imidazolyl aldosterone synthase or aromatase inhibitor

Publications (1)

Publication Number	Publication Date
IN2014DN06781A true IN2014DN06781A (da)	2015-05-22

Family

ID=47604250

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN6781DEN2014 IN2014DN06781A (da)	2012-01-17	2013-01-15

Country Status (40)

Country	Link
US (2)	US9334276B2 (da)
EP (1)	EP2804863B1 (da)
JP (1)	JP5749410B2 (da)
KR (2)	KR20140141687A (da)
CN (1)	CN104039793B (da)
AP (1)	AP2014007762A0 (da)
AR (1)	AR089728A1 (da)
AU (1)	AU2013209952B2 (da)
BR (1)	BR112014017260A8 (da)
CA (1)	CA2863339C (da)
CL (1)	CL2014001863A1 (da)
CO (1)	CO7000775A2 (da)
CR (1)	CR20140345A (da)
CU (1)	CU20140086A7 (da)
CY (1)	CY1117914T1 (da)
DK (1)	DK2804863T3 (da)
EA (1)	EA026232B1 (da)
ES (1)	ES2564143T3 (da)
GT (1)	GT201400155A (da)
HR (1)	HRP20160178T1 (da)
HU (1)	HUE026984T2 (da)
IL (1)	IL233541B (da)
IN (1)	IN2014DN06781A (da)
JO (1)	JO3137B1 (da)
MA (1)	MA35858B1 (da)
MX (1)	MX2014008686A (da)
NZ (1)	NZ626277A (da)
PE (1)	PE20142358A1 (da)
PH (1)	PH12014501638B1 (da)
PL (1)	PL2804863T3 (da)
RS (1)	RS54589B1 (da)
SG (1)	SG11201404061YA (da)
SI (1)	SI2804863T1 (da)
SM (1)	SMT201600083B (da)
TN (1)	TN2014000256A1 (da)
TW (1)	TWI609869B (da)
UA (1)	UA114803C2 (da)
UY (1)	UY34576A (da)
WO (1)	WO2013109514A1 (da)
ZA (1)	ZA201404314B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5602250B2 (ja) *	2010-01-14	2014-10-08	ノバルティスアーゲー	副腎ホルモン修飾剤の使用
EP2815749A1 (en)	2013-06-20	2014-12-24	IP Gesellschaft für Management mbH	Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
PE20170201A1 (es) *	2014-07-07	2017-04-08	Novartis Ag	Formas de dosificacion farmaceutica
EP3250555B1 (en) *	2015-01-29	2021-03-03	Recordati AG	Process for the production of condensed imidazolo derivatives
US20160287565A1 (en) *	2015-04-06	2016-10-06	Millendo Therapeutics, Inc.	Combination therapy for treating disorders associated with excess cortisol production
WO2018078049A1 (en) *	2016-10-27	2018-05-03	Damian Pharma Ag	Aldosterone synthase inhibitor
KR102923585B1 (ko)	2016-10-27	2026-02-04	다미안 파르마 에이쥐	알도스테론 합성효소 저해제
AU2019262310B2 (en)	2018-05-03	2025-03-13	Damian Pharma Ag	R-fadrozole for use in the treatment of aldostonerism

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1315449A (en) *	1918-11-15	1919-09-09	Frank B Yingling	Shaper-feed.
US4617307A (en) *	1984-06-20	1986-10-14	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5066656A (en)	1989-11-01	1991-11-19	Janssen Pharmaceutica N.V.	Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
MTP1076B (en) *	1990-01-12	1991-09-30	Ciba Geigy Ag	Hemihydrate
CA2127689A1 (en)	1992-01-27	1993-08-05	Marcel A. C. Janssen	Pyrroloimidazolyl and imidazopyridinyl substituted 1h-benzimidazole derivatives as aromatase inhibitors
CN100447142C (zh)	2002-11-18	2008-12-31	诺瓦提斯公司	咪唑并[1,5a]吡啶衍生物及治疗醛固酮所介导疾病的方法
GT200600381A (es) *	2005-08-25	2007-03-28		Compuestos organicos
EP2094669A2 (en)	2006-12-18	2009-09-02	Novartis AG	1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
ES2472446T3 (es)	2009-11-30	2014-07-01	Novartis Ag	Derivados de imidazol como inhibidores de aldosterona sintasa
JP5602250B2 (ja) *	2010-01-14	2014-10-08	ノバルティスアーゲー	副腎ホルモン修飾剤の使用

2013
- 2013-01-15 EP EP13701194.6A patent/EP2804863B1/en active Active
- 2013-01-15 UY UY0001034576A patent/UY34576A/es not_active Application Discontinuation
- 2013-01-15 SG SG11201404061YA patent/SG11201404061YA/en unknown
- 2013-01-15 CN CN201380005054.0A patent/CN104039793B/zh active Active
- 2013-01-15 RS RS20160109A patent/RS54589B1/sr unknown
- 2013-01-15 US US14/370,124 patent/US9334276B2/en active Active
- 2013-01-15 CA CA2863339A patent/CA2863339C/en active Active
- 2013-01-15 UA UAA201406492A patent/UA114803C2/uk unknown
- 2013-01-15 JP JP2014552375A patent/JP5749410B2/ja active Active
- 2013-01-15 ES ES13701194.6T patent/ES2564143T3/es active Active
- 2013-01-15 KR KR20147030158A patent/KR20140141687A/ko not_active Ceased
- 2013-01-15 MX MX2014008686A patent/MX2014008686A/es unknown
- 2013-01-15 WO PCT/US2013/021521 patent/WO2013109514A1/en not_active Ceased
- 2013-01-15 NZ NZ626277A patent/NZ626277A/en not_active IP Right Cessation
- 2013-01-15 PL PL13701194T patent/PL2804863T3/pl unknown
- 2013-01-15 PE PE2014001112A patent/PE20142358A1/es not_active Application Discontinuation
- 2013-01-15 AU AU2013209952A patent/AU2013209952B2/en active Active
- 2013-01-15 HR HRP20160178T patent/HRP20160178T1/hr unknown
- 2013-01-15 IN IN6781DEN2014 patent/IN2014DN06781A/en unknown
- 2013-01-15 EA EA201491374A patent/EA026232B1/ru not_active IP Right Cessation
- 2013-01-15 BR BR112014017260A patent/BR112014017260A8/pt not_active Application Discontinuation
- 2013-01-15 KR KR1020147016954A patent/KR20140093726A/ko not_active Ceased
- 2013-01-15 AR ARP130100119A patent/AR089728A1/es unknown
- 2013-01-15 SI SI201330142A patent/SI2804863T1/sl unknown
- 2013-01-15 JO JOP/2013/0014A patent/JO3137B1/ar active
- 2013-01-15 HU HUE13701194A patent/HUE026984T2/en unknown
- 2013-01-15 TW TW102101537A patent/TWI609869B/zh not_active IP Right Cessation
- 2013-01-15 DK DK13701194.6T patent/DK2804863T3/da active
- 2013-01-15 AP AP2014007762A patent/AP2014007762A0/xx unknown
2014
- 2014-06-11 ZA ZA2014/04314A patent/ZA201404314B/en unknown
- 2014-06-12 TN TNP2014000256A patent/TN2014000256A1/en unknown
- 2014-07-07 IL IL233541A patent/IL233541B/en active IP Right Grant
- 2014-07-08 CO CO14146898A patent/CO7000775A2/es unknown
- 2014-07-11 MA MA37199A patent/MA35858B1/fr unknown
- 2014-07-15 CU CU2014000086A patent/CU20140086A7/es unknown
- 2014-07-15 CL CL2014001863A patent/CL2014001863A1/es unknown
- 2014-07-17 CR CR20140345A patent/CR20140345A/es unknown
- 2014-07-17 GT GT201400155A patent/GT201400155A/es unknown
- 2014-07-17 PH PH12014501638A patent/PH12014501638B1/en unknown
2016
- 2016-02-09 US US15/018,953 patent/US20160176883A1/en not_active Abandoned
- 2016-02-26 CY CY20161100163T patent/CY1117914T1/el unknown
- 2016-03-23 SM SM201600083T patent/SMT201600083B/xx unknown

Also Published As

Publication number	Publication date
US20160176883A1 (en)	2016-06-23
BR112014017260A8 (pt)	2017-07-04
EA201491374A1 (ru)	2014-12-30
WO2013109514A1 (en)	2013-07-25
MX2014008686A (es)	2014-08-27
CO7000775A2 (es)	2014-07-21
CN104039793B (zh)	2017-05-10
IL233541B (en)	2018-12-31
SI2804863T1 (sl)	2016-05-31
TWI609869B (zh)	2018-01-01
PE20142358A1 (es)	2015-01-30
UA114803C2 (uk)	2017-08-10
NZ626277A (en)	2015-10-30
ES2564143T3 (es)	2016-03-18
SMT201600083B (it)	2016-04-29
CU20140086A7 (es)	2014-12-26
JP5749410B2 (ja)	2015-07-15
CR20140345A (es)	2014-09-09
PH12014501638A1 (en)	2014-10-13
ZA201404314B (en)	2015-08-26
EP2804863A1 (en)	2014-11-26
TW201335161A (zh)	2013-09-01
ES2564143T8 (es)	2020-11-18
IL233541A0 (en)	2014-08-31
MA35858B1 (fr)	2014-12-01
EP2804863B1 (en)	2015-12-02
CL2014001863A1 (es)	2014-11-07
CY1117914T1 (el)	2017-05-17
AU2013209952B2 (en)	2016-09-01
RS54589B1 (sr)	2016-08-31
CN104039793A (zh)	2014-09-10
BR112014017260A2 (pt)	2017-06-13
KR20140093726A (ko)	2014-07-28
US20140364470A1 (en)	2014-12-11
AU2013209952A1 (en)	2014-07-24
HRP20160178T1 (hr)	2016-03-25
JP2015503627A (ja)	2015-02-02
UY34576A (es)	2013-09-02
CA2863339A1 (en)	2013-07-25
GT201400155A (es)	2017-09-28
EA026232B1 (ru)	2017-03-31
US9334276B2 (en)	2016-05-10
PH12014501638B1 (en)	2014-10-13
HK1198536A1 (en)	2015-05-15
AR089728A1 (es)	2014-09-10
JO3137B1 (ar)	2017-09-20
PL2804863T3 (pl)	2016-06-30
HUE026984T2 (en)	2016-08-29
AP2014007762A0 (en)	2014-07-31
CA2863339C (en)	2021-03-23
DK2804863T3 (da)	2016-03-07
TN2014000256A1 (en)	2015-09-30
SG11201404061YA (en)	2014-08-28
KR20140141687A (ko)	2014-12-10

Publication	Publication Date	Title
IN2014DN06781A (da)	2015-05-22
IL235659A (en)	2017-02-28	History 3, 4 - Dihydro-h2 - Pyrido [1, 2 - a] Pyrazine – 1, 6 - Transformed deion used to treat (among other things) Alzheimer's disease
PH12013500872A1 (en)	2016-04-01	Salt(s) of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
IN2014DN07384A (da)	2015-04-24
MX2020011079A (es)	2020-11-09	Forma cristalina de sulfato acido de (s)-n-(5-((r)-2-(2,5-difluoro fenil)-pirrolidin-1-il)-pirazolo[1,5-a]-pirimidin-3-il)-3-hidroxi pirrolidina-1-carboxamida.
PL3808749T3 (pl)	2023-07-10	Pirazolo[1,5-a]pirymidyny użyteczne jako inhibitory kinazy atr do leczenia chorób nowotworowych
PH12015500988B1 (en)	2018-05-25	Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
MX347917B (es)	2017-05-17	Compuestos a base de imidazo[1,2-b]piridazina, composiciones que los comprenden, y metodos para su uso.
GEP20156285B (en)	2015-05-11	Compounds and compositions as trk inhibitors
HRP20182007T1 (hr)	2019-01-25	Derivati 3-okso-2,3,5,8-tetrahidro-[1,2,4]triazolo[4,3-a]pirimidina za liječenje respiratornih bolesti
HK1216425A1 (zh)	2016-11-11	基於2，3-二氢咪唑并[1，2-c]嘧啶-5(1h)-酮的脂蛋白相关磷脂酶a2(lp-pla2)抑制剂
MX2012002327A (es)	2012-04-10	Inhibidores de cinasa, formas de profarmaco de los mismos y su uso en terapia.
TN2013000377A1 (en)	2015-01-20	Thieno [2, 3-d] pyrimidine derivatives and their use to treat arrhythmia
TN2013000483A1 (en)	2015-03-30	Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives
MX384986B (es)	2025-03-14	Sal y formas polimorficas de (3r,4s)-l-((4-amino-5h-pirrolo[3,2-d]pirimidin-7-il)metil)-4(metiltiometil)pirodin-3-ol(mtdia).
TN2013000146A1 (en)	2014-06-25	Salt(s) of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
HK1173146A (en)	2013-05-10	Kinase inhibitors, prodrug forms thereof and their use in therapy